Clinical Trials Directory

Trials / Unknown

UnknownNCT04293328

Monthly Replacement Orthokeratology for Myopia Control in Young Children

Accrued Effect of Orthokeratology for Myopia Control in Children and the Effectiveness of Myopia Control Using an Innovative Orthokeratology Modality. Experiment 2. Effect in New Ortho-k Wearers

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
The Hong Kong Polytechnic University · Academic / Other
Sex
All
Age
6 Years – 10 Years
Healthy volunteers
Accepted

Summary

The two-year prospective study aims at investigating frequently replacement effect on myopia control in young children, and the use of weekly protein removal system in monthly replacement modality orthokeratology lenses on surface deposit.

Detailed description

In this two-year prospective study, low myopic children, aged 6-8 years, who have no prior experience in contact lens wear and myopia control treatment will be recruited. They will be prescribed with monthly replacement orthokeratology lenses for a period of one year. Axial elongation and ocular conditions during the study will be determined. Subjects will be randomly assigned to normal cleaning and intensive cleaning groups. Subjects in normal cleaning group will be provided with complimentary contact lenses solutions for daily cleaning and disinfection. In addition to the daily procedures for lens case, subjects in the intensive cleaning group will be required to perform weekly protein removal.

Conditions

Interventions

TypeNameDescription
DEVICEorthokeratologyNightly wear of orthokeratology lenses to correct vision in the daytime
DEVICEMenicon Progent A+BMenicon Progent A+B is a commercially available protein remover for rigid lenses. It has received FDA clearance and been launched in Hong Kong for over a decade. The product contains two separate sterile solutions, one with sodium hypochlorite and the other with potassium bromide. By mixing the two solutions in a special vial, it can clean and remove protein deposits on the lenses. Parents of subjects assigned to use weekly protein remover will be required to soak the cleansed lenses in the solution mixture for not more than 30 mins every week. All lenses must be rinsed thoroughly with saline and cleansed with daily cleaner again before daily disinfection.

Timeline

Start date
2020-07-07
Primary completion
2023-06-01
Completion
2023-08-01
First posted
2020-03-03
Last updated
2022-07-20

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT04293328. Inclusion in this directory is not an endorsement.